Xiaoping Wang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 10
- Cancer Cells and Metastasis 8
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 3
- Immunology 15
- Immune cells in cancer 4
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3
- Co-authors
- Naoto T. Ueno (27 shared papers)Bora Lim (7 shared papers)Wendy A. Woodward (10 shared papers)James M. Reuben (9 shared papers)Xia Shen (1 shared paper)Qiujing Li (1 shared paper)Huiyong Yin (1 shared paper)Yongzhen Tao (1 shared paper)
- Journals
- Cancer Research (6 papers)Proceedings of the National Academy of Sciences (3 papers)Breast Cancer Research and Treatment (3 papers)Nature reviews. Cancer (2 papers)Molecular Therapy — Oncolytics (2 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Xiaoping Wang
44 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 109
- Cancer Research 247
- Oncology 413
- Immunology 307
- Molecular Biology 560
- Biochemistry 37
Countries citing papers authored by Xiaoping Wang
This map shows the geographic impact of Xiaoping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Wang more than expected).
Fields of papers citing papers by Xiaoping Wang
This network shows the impact of papers produced by Xiaoping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Wang. The network helps show where Xiaoping Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 271 | |
| 2 | 2018 | 242 | |
| 3 | 2012 | 86 | |
| 4 | 2020 | 68 | |
| 5 | 2013 | 65 | |
| 6 | 2021 | 60 | |
| 7 | 2021 | 50 | |
| 8 | 2017 | 38 | |
| 9 | 2014 | 37 | |
| 10 | 2007 | 36 | |
| 11 | 2017 | 34 | |
| 12 | 2017 | 29 | |
| 13 | 2017 | 28 | |
| 14 | 2019 | 27 | |
| 15 | 2007 | 23 | |
| 16 | 2020 | 22 | |
| 17 | 1999 | 21 | |
| 18 | 2008 | 19 | |
| 19 | 2021 | 19 | |
| 20 | 2015 | 17 |
About Xiaoping Wang
Xiaoping Wang is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 46 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Cancer Cells and Metastasis (8 papers), HER2/EGFR in Cancer Research (7 papers), Immune cells in cancer (4 papers), Cancer Treatment and Pharmacology (3 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Cancer Research (247 citations), Oncology (413 citations), Immunology (307 citations), Molecular Biology (560 citations) and Biochemistry (37 citations). Xiaoping Wang has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Naoto T. Ueno, Bora Lim, Wendy A. Woodward, James M. Reuben, Xia Shen, Qiujing Li, Huiyong Yin, Yongzhen Tao, Wenxin Xu and Luxiao Li. Their work appears in journals such as Cancer Research, Proceedings of the National Academy of Sciences, Breast Cancer Research and Treatment, Nature reviews. Cancer and Molecular Therapy — Oncolytics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.